Edition:
United Kingdom

Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

171.87USD
12 Dec 2017
Change (% chg)

$-0.89 (-0.52%)
Prev Close
$172.76
Open
$173.11
Day's High
$174.00
Day's Low
$171.66
Volume
436,421
Avg. Vol
628,428
52-wk High
$256.78
52-wk Low
$160.09

Chart for

About

Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US... (more)

Overall

Beta: 1.17
Market Cap(Mil.): $69,117.80
Shares Outstanding(Mil.): 334.31
Dividend: 0.70
Yield (%): 1.35

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Allergan Receives FDA Clearance For The CoolSculpting Treatment To Improve Appearance Of Lax Tissue In The Double Chin

* ALLERGAN RECEIVES FDA CLEARANCE FOR THE COOLSCULPTING TREATMENT TO IMPROVE APPEARANCE OF LAX TISSUE IN THE DOUBLE CHIN Source text for Eikon: Further company coverage:

12 Dec 2017

BRIEF-Repros Therapeutics Announces Acquisition By Allergan

* REPROS THERAPEUTICS INC.® ANNOUNCES ACQUISITION BY ALLERGAN PLC

12 Dec 2017

Teva considering cutting up to 10,000 jobs: Bloomberg

Teva Pharmaceutical Industries Ltd is considering cutting up to 10,000 jobs as CEO Kare Schultz seeks to reduce $1.5 billion to $2 billion in costs over the next two years, Bloomberg reported, citing people familiar with the matter.

08 Dec 2017

UPDATE 2-Teva considering cutting up to 10,000 jobs - Bloomberg

Dec 8 Teva Pharmaceutical Industries Ltd is considering cutting up to 10,000 jobs as CEO Kare Schultz seeks to reduce $1.5 billion to $2 billion in costs over the next two years, Bloomberg reported, citing people familiar with the matter.

08 Dec 2017

Fitch Affirms Allergan's 'BBB-' Rating; Outlook Stable

(The following statement was released by the rating agency) CHICAGO, December 07 (Fitch) Fitch Ratings has affirmed the ratings of Allergan plc (Allergan; NYSE: AGN) and subsidiaries at 'BBB-'. The Rating Outlook is Stable. Fitch has also affirmed and withdrawn the 'BBB-' IDRs of Allergan's subsidiaries, Warner Chilcott Limited and Allergan Finance LLC. These IDRs are no longer considered by Fitch to be relevant to the agency's coverage. A full list of rating actions, which apply to approximatel

07 Dec 2017

Tech firms tell patent court to ignore Allergan deal with tribe

Over 30 technology companies including Alphabet Inc , Amazon.com Inc and Facebook Inc. on Friday urged a U.S. patent court to disregard drugmaker Allergan Plc's contention that its transfer of some of its patents to a Native American tribe shields them from the court's review.

01 Dec 2017

Tech firms tell patent court to ignore Allergan deal with tribe

Dec 1 Over 30 technology companies including Alphabet Inc, Amazon.com Inc and Facebook Inc. on Friday urged a U.S. patent court to disregard drugmaker Allergan Plc's contention that its transfer of some of its patents to a Native American tribe shields them from the court's review.

01 Dec 2017

UPDATE 2-Teva Pharmaceutical set for major layoffs in Israel, U.S. -report

TEL AVIV, Nov 23 Teva Pharmaceutical is expected to cut up to a quarter of its 6,860-strong workforce in Israel, and a few thousand more staff in the United States, media reported Thursday, though a minister said the figures may not be accurate.

23 Nov 2017

Teva Pharmaceutical set for major layoffs in Israel, U.S.: report

TEL AVIV Teva Pharmaceutical Industries is expected to cut 20-25 percent of its workforce in Israel, where it employs 6,860 people, and a few thousand more jobs are to go in the United States, financial news website Calcalist said on Thursday.

23 Nov 2017

Teva Pharmaceutical set for major layoffs in Israel, U.S. -report

TEL AVIV, Nov 23 Teva Pharmaceutical Industries is expected to cut 20-25 percent of its 6,860 workers in Israel and a few thousand more in the United States, financial news website Calcalist reported on Thursday.

23 Nov 2017

Earnings vs. Estimates